Immunic AG Logo

Immunic AG

IMUX | NDAQ

Overview

Corporate Details

ISIN(s):
US4525EP1011
LEI:
549300R5T12FW5MEQB20
Country:
United States of America
Address:
C/O The Corporation Trust Company, 19801 Wilmington
Sector:
Health Care
Industry:
Biotechnology

Description

No description available.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-24 12:30
Regulatory News Service
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 …
English 15.2 KB
2025-06-05 12:30
Earnings Release
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Re…
English 18.3 KB
2025-06-02 12:30
Regulatory News Service
Immunic to Participate in Investor, Scientific and Industry Conferences in June
English 13.9 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BSF ENTERPRISE PLC Logo BSF ENTERPRISE PLC United Kingdom BSFA
Can-Fite BioPharma Ltd. Logo Can-Fite BioPharma Ltd. Israel CANF
Cantargia Logo Cantargia Sweden CANTA
Captor Therapeutics S.A. Logo Captor Therapeutics S.A. Poland CTX
Carbiotix AB Logo Carbiotix AB Sweden CRBX
Cellectis Logo Cellectis France ALCLS
CELLULAR GOODS PLC Logo CELLULAR GOODS PLC United Kingdom CBX
Celyad Oncology SA Logo Celyad Oncology SA Belgium CYAD
Cereno Scientific AB Logo Cereno Scientific AB Sweden CRNO
Cessatech A/S Logo Cessatech A/S Denmark CESSA